AptarGroup, Inc. 10-Q Summary: Quarter Ended June 30, 1999
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 1999, and the six-month period ended on that date. AptarGroup, Inc. is a manufacturer of closure and dispensing systems for the pharmaceutical, personal care, and food markets. The company operates globally, with significant exposure to European currencies (French Franc, German Mark, Italian Lira). During the period, the company completed a major acquisition of Emson Research, Inc., a leading supplier of perfume pumps.
Key Financial Metrics
| Metric | Q2 1999 | Q2 1998 | YTD 1999 | YTD 1998 |
|---|---|---|---|---|
| Net Sales | $208.9M | $181.8M | $407.1M | $352.7M |
| Operating Income | $28.3M | $24.8M | $52.6M | $47.3M |
| Net Income | $16.2M | $14.3M | $30.4M | $27.4M |
| Diluted EPS | $0.44 | $0.39 | $0.82 | $0.75 |
| Operating Margin | 13.6% | 13.7% | 12.9% | 13.4% |
| Effective Tax Rate | 35.2% | 40.3% | 35.3% | 40.3% |
Liquidity and Debt: Cash and equivalents stood at $32.6 million as of June 30, 1999. Net cash provided by operating activities for the six months was $66.3 million. The company entered into a $107 million private debt placement and a $75 million revolving credit agreement to fund acquisitions and operations. The ratio of net debt to total net capitalization increased to 34.7% from 18.3% at year-end 1998.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15% year-over-year for the quarter and 15% for the six-month period. Acquisitions accounted for $32 million of the quarterly increase and $55 million of the six-month increase.
- Profitability: Net income rose 13% in the quarter and 11% year-to-date. The effective tax rate decreased significantly due to reductions in French and German corporate tax rates.
- Acquisition Impact: The acquisition of Emson Research, Inc. for approximately $123 million in cash and stock (plus $23 million assumed debt) drove a significant increase in goodwill (from $49.7M to $124.1M) and capital expenditures.
- Expense Trends: SG&A expenses increased 12.4% in the quarter, entirely attributable to acquisitions. Cost of sales as a percentage of net sales improved slightly to 62.2% in Q2 1999 from 62.6% in Q2 1998.
- Currency Impact: A stronger U.S. dollar negatively impacted the translation of foreign sales by approximately 2% in the quarter. Without currency effects, sales growth would have been 17%.
Guidance, Outlook, and Risks
- Capital Expenditures: Management anticipates total capital expenditures for 1999 to be approximately $85 million to $90 million.
- Tax Outlook: The company expects the effective tax rate for the full year 1999 to be in the range of 35% to 36%.
- Dividends: The Board declared a quarterly dividend of $0.05 per share, a 25% increase over the prior rate.
- Year 2000 (Y2K) Readiness: The company is in the testing/validation phase of its Y2K program, with projected costs of $3.5 million. While no material disruption is currently anticipated from suppliers or customers, a worst-case scenario involving facility interruptions could materially impact operations.
- Seasonality: Results in the second half of the year are typically negatively impacted by European summer holidays and customer plant shutdowns in December.
Investor Verification Checklist
- Verify the integration progress and revenue contribution of the Emson Research acquisition.
- Monitor the impact of the strong U.S. dollar on future European sales translation.
- Confirm the status of Y2K compliance testing and contingency plans for critical production facilities.
- Review the company's ability to meet debt covenants (interest coverage, net worth) given the increased leverage from the $107 million note issuance.
- Assess the sustainability of the improved effective tax rate given the mix of foreign income.